Rishi Gupta - Feb 23, 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: Director, 10%+ Owner
Signature: /s/ Ben Hohl, by power of attorney
Stock symbol: ELVN
Transactions as of: Feb 23, 2023
Transactions value $: $0
Form type: 3
Date filed: 2/27/2023, 08:48 PM
Previous filing: Dec 27, 2022
Next filing: Apr 28, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney